Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TIKOSYN®Principal Display Panel (dofetilide)

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5800-60

Tikosyn®

(dofetilide) Capsules

125 mcg (0.125 mg)

60 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Blister Pack

FOR INSTITUTION USE

Tikosyn®

(dofetilide) Capsule

125mcg (0.125mg)

PFIZER LABS
DIV. OF PFIZER INC, NY, NY 10017

LOT: XXXXXXX
EXP: YYYY MMM

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Blister Pack

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Blister Pack Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5800-43

Tikosyn®

(dofetilide) capsules

125 mcg (0.125 mg)

For in-institution use only

40 Capsules

Rx only
UNIT DOSE

PRINCIPAL DISPLAY PANEL - 0.125 mg Capsule Blister Pack Carton

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5810-60

Tikosyn®

(dofetilide) Capsules

250 mcg (0.25 mg)

60 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Blister Pack

FOR INSTITUTION USE

Tikosyn®

(dofetilide) Capsule

250mcg (0.25mg)

PFIZER LABS
DIV. OF PFIZER INC, NY, NY 10017

LOT: XXXXXXX
EXP: YYYY MMM

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Blister Pack

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Blister Pack Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5810-43

Tikosyn®

(dofetilide) capsules

250 mcg (0.25 mg)

For in-institution use only

40 Capsules

Rx only
UNIT DOSE

PRINCIPAL DISPLAY PANEL - 0.25 mg Capsule Blister Pack Carton

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Bottle Label

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5820-60

Tikosyn®

(dofetilide) Capsules

500 mcg (0.5 mg)

60 Capsules
Rx only

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Bottle Label

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Blister Pack

FOR INSTITUTION USE

Tikosyn®

(dofetilide) Capsule

500mcg (0.5mg)

PFIZER LABS
DIV. OF PFIZER INC, NY, NY 10017

LOT: XXXXXXX
EXP: YYYY MMM

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Blister Pack

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Blister Pack Carton

ALWAYS DISPENSE WITH MEDICATION GUIDE

Pfizer
NDC 0069-5820-43

Tikosyn®

(dofetilide) capsules

500 mcg (0.5 mg)

For in-institution use only

40 Capsules

Rx only
UNIT DOSE

PRINCIPAL DISPLAY PANEL - 0.5 mg Capsule Blister Pack Carton
Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No

Resources

website
Tikosyn Website for Healthcare Professionals
 
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.